Ken Walz

Ken Walz is a co-founder of Popper and Company, a strategy and M&A advisory firm focusing on healthcare innovation. With over 25 years of experience in the medical technology field, he caters to a diverse clientele including start-ups, Fortune 100 companies, academic institutions, and investors. Ken is dedicated to helping companies thrive in the evolving healthcare landscape and shape the future marketplace.

In 2003, Ken Walz co-founded Popper and Company with Caroline Popper, aiming to assist businesses in developing and commercializing technology, enhancing healthcare delivery, and supporting empowered healthcare consumers. Their multidisciplinary team, comprising physician entrepreneurs, analysts, engineers, scientists, and clinicians, collaborates to deliver innovative ideas and solutions to clients.

Ken Walz holds an MSF in Finance from Loyola College in Maryland and a BA in Economics from the University of Maryland Baltimore County. His extensive background includes roles such as Co-founder and Partner at Popper and Company LLC, Former Principal at Eaton Square, Former Reviewer at Maryland Technology Development Corporation (TEDCO), Former VP Commercial Development at MDS Proteomics, and Former Manager at BD Gene at Becton Dickinson.

For cutting-edge insights, intelligence, and solutions to overcome business challenges and drive growth, connect with Ken Walz and the Popper and Company team through their website at www.popperandco.com or by calling (410) 246-6524.